These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17044661)

  • 1. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
    Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
    Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
    Morimoto S; Jo F; Maki K; Iwasaka T
    Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
    Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
    Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
    Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
    Isaka T; Ikeda K; Takada Y; Inada Y; Tojo K; Tajima N
    Eur J Pharmacol; 2009 Mar; 605(1-3):49-52. PubMed ID: 19168055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis.
    Aritomi S; Wagatsuma H; Numata T; Uriu Y; Nogi Y; Mitsui A; Konda T; Mori Y; Yoshimura M
    Hypertens Res; 2011 Feb; 34(2):193-201. PubMed ID: 20981032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
    Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
    Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.